Benefit of measuring basal serum calcitonin to detect medullary thyroid carcinoma in a Danish population with a high prevalence of thyroid nodules

Head & Neck ◽  
2009 ◽  
pp. NA-NA ◽  
Author(s):  
Martin Hasselgren ◽  
Laszlo Hegedüs ◽  
Christian Godballe ◽  
Steen Joop Bonnema



2014 ◽  
Vol 82 (4) ◽  
pp. 598-603 ◽  
Author(s):  
Hyemi Kwon ◽  
Won Gu Kim ◽  
Yun Mi Choi ◽  
Eun Kyung Jang ◽  
Min Ji Jeon ◽  
...  


Author(s):  
Luca Giovanella ◽  
Frederik A. Verburg ◽  
Mauro Imperiali ◽  
Stefano Valabrega ◽  
Pierpaolo Trimboli ◽  
...  


Author(s):  
Entela Puca ◽  
Kadir Burak Koza ◽  
Emiljana Huti ◽  
Sonila Bitri ◽  
Albana Daka ◽  
...  


1999 ◽  
pp. 286-289 ◽  
Author(s):  
B Mayr ◽  
G Brabant ◽  
A von zur Muhlen

Serum calcitonin screening has recently been found to be a useful supplement to fine-needle aspiration biopsy, ultrasound and radionuclide imaging in the evaluation of thyroid nodules. We describe a case where introduction of routine calcitonin screening in nodular thyroid disease led to the detection of a family with medullary thyroid carcinoma. The benefits and problems of basal and stimulated serum calcitonin testing and ret-proto-oncogene mutation studies are exemplified and we discuss the appropriate use and interpretation of these tests. We conclude that routine basal serum calcitonin measurement in nodular thyroid disease and thoughtful use of ret-mutation analysis is cost-effective in detecting medullary thyroid carcinoma and multiple endocrine neoplasia type II.



Thyroid ◽  
1999 ◽  
Vol 9 (6) ◽  
pp. 579-582 ◽  
Author(s):  
A. GÖKHAN ÖZGEN ◽  
FÜSUN HAMULU ◽  
FIRAT BAYRAKTAR ◽  
CANDEĞER YILMAZ ◽  
MEHMET TÜZÜN ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document